The Project aims at development of National biomedicine research platform addressing public health challenges in RIS3 domain \\\"Biomedicine, medical technologies, biopharmacy and biotechnologies\\\" in line with the mission statement of the State Research Program. To reach the aim of the project the following Objectives will be pursued: 1. Development of new products, technologies, and methods via selected pilot projects; 2. Enhancement of scholarly output, especially by increase of multidisciplinary and interinstitutional research publications; 3. Development of HR research capital both by the advancement of the research profile of established scientists and academic education; 4. Development of knowledge base to support collaboration with industry including hospitals as well as applications for translational research projects and participation in international research consortia. Project partners: Latvian Institute of Organic Synthesis (LIOS, coordinator), Riga Technical University (RTU), University of Latvia (UL), Riga Stradins University (RSU), Institute of Food Safety, Animal Health and Environment (BIOR), Latvian Biomedical Research and Study Center (BMC). Project duration: 24 months. Total funding: EUR 5 700 000.
|Effective start/end date||1/12/22 → 30/11/24|
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
- personalized medicine
- cardiometabolic diseases
- antiinfectives and vaccines
- biomaterials and drug delivery
- AMR ecosystem
Field of Science
- 2.5 Materials engineering
- 3.2 Clinical medicine
- 3.1 Basic medicine
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.